Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
[Research cited on Manufacture Website]. ✅
Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0
Pub: 2018 Jan Epub: Authors Miyarisan Labs ,
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345
Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ ,
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345
Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ ,
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345
Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ ,
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345
Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ ,
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345
Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Dietary Clostridium butyricum Induces a Phased Shift in Fecal Microbiota Structure and Increases the Acetic Acid-Producing Bacteria in a Weaned Piglet Model. ✅ Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 66 Issue 20 Pages: 5157-5166
Pub: 2018 May 23 Epub: 2018 Apr 30 Authors Zhang J , Chen X , Liu P , Zhao J , Sun J , Guan W , Johnston LJ , Levesque CL , Fan P , He T , Zhang G , Ma X ,
The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue. ✅ Go to Publication ✅
Anaerobe (Anaerobe ) Vol: 54 Issue Pages: 8-18
Pub: 2018 Dec Epub: 2018 Aug 1 Authors Hagihara M , Yamashita R , Matsumoto A , Mori T , Kuroki Y , Kudo H , Oka K , Takahashi M , Nonogaki T , Yamagishi Y , Mikamo H ,
The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue. ✅ Go to Publication ✅
Anaerobe (Anaerobe ) Vol: 54 Issue Pages: 8-18
Pub: 2018 Dec Epub: 2018 Aug 1 Authors Hagihara M , Yamashita R , Matsumoto A , Mori T , Kuroki Y , Kudo H , Oka K , Takahashi M , Nonogaki T , Yamagishi Y , Mikamo H ,
Effects of Dietary Supplementation With Clostridium butyricum on the Amelioration of Growth Performance, Rumen Fermentation, and Rumen Microbiota of Holstein Heifers. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 763700
Pub: 2021 Epub: 2021 Nov 11 Authors Li Y , Wang Y , Lv J , Dou X , Zhang Y ,
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891
Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G ,
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891
Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G ,
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891
Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G ,
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891
Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G ,
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891
Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G ,
Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis? ✅ Go to Publication ✅
mSystems (mSystems ) Vol: Issue Pages: e0073223
Pub: 2023 Nov 3 Epub: 2023 Nov 3 Authors Tao R , Zong G , Pan Y , Li H , Cheng P , Deng R , Chen W , Wang A , Xia S , Tang W , Lu Y , Wei Z ,
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅ Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332
Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R ,
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅ Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332
Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R ,
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅ Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332
Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R ,
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅ Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332
Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R ,
Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation. ✅ Go to Publication ✅
Bone marrow transplantation (Bone Marrow Transplant ) Vol: 59 Issue 6 Pages: 795-802
Pub: 2024 Jun Epub: 2024 Mar 2 Authors Fukushima K , Kudo H , Oka K , Hayashi A , Onizuka M , Kusakabe S , Hino A , Takahashi M , Takeda K , Mori M , Ando K , Hosen N ,

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)